Current Molecular Pharmacology
Title:Natural Products and Cardiovascular Diseases
Volume: 14
Author(s): Kunming Tian and Suowen Xu
Affiliation:
Export Options
About this article
Cite this article as:
Tian Kunming and Xu Suowen , Natural Products and Cardiovascular Diseases, Current Molecular Pharmacology 2021; 14 (6) : e201221199175 . https://dx.doi.org/10.2174/187446721406211220144326
DOI https://dx.doi.org/10.2174/187446721406211220144326 |
Print ISSN 1874-4672 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4702 |
20
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Oxidative Stress Induced Mitochondrial DNA Deletion as a Hallmark forthe Drug Development in the Context of the Cerebrovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Neurodegenerative Diseases of the Retina and Potential for Protection and Recovery
Current Neuropharmacology Cholinesterases: Roles in the Brain During Health and Disease
Current Alzheimer Research Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-diabetic Diseases
Mini-Reviews in Medicinal Chemistry Alternative Routes for the Formation of Immunochemically Distinct Advanced Glycation End-products In Vivo
Current Molecular Medicine Patent Selections
Recent Patents on Biomarkers Amyloidosis and Auto-Inflammatory Syndromes
Current Drug Targets - Inflammation & Allergy Small Artery Remodeling in Obesity and Insulin Resistance
Current Vascular Pharmacology Silent Cerebral Damage in Hypertension
Current Hypertension Reviews Interactions Between Plasma Proteins and Naturally Occurring Polyphenols
Current Drug Metabolism Gene Regulation of Aldose-, Aldehyde- and a Renal Specific Oxido Reductase (RSOR) in the Pathobiology of Diabetes Mellitus
Current Medicinal Chemistry Gene Therapy for Ischemic Brain Diseases
Current Gene Therapy High-Density Lipoprotein at the Interface of Type 2 Diabetes Mellitus And Cardiovascular Disorders
Current Pharmaceutical Design Sirolimus Early Graft Nephrotoxicity: Clinical and Experimental Data
Current Drug Safety Insulin-Degrading Enzyme: Structure-Function Relationship and its Possible Roles in Health and Disease
Current Pharmaceutical Design Genetic Markers in Biological Fluids for Aging-Related Major Neurocognitive Disorder
Current Alzheimer Research Advanced Glycation: How are we Progressing to Combat this Web of Sugar Anomalies in Diabetic Nephropathy
Current Pharmaceutical Design Adult Changes in Thought Study: Dementia is an Individually Varying Convergent Syndrome with Prevalent Clinically Silent Diseases that may be Modified by Some Commonly Used Therapeutics
Current Alzheimer Research A Therapeutic Target for Microvascular Complications in Diabetes: Endothelium- Derived Hyperpolarizing Factor
Current Cardiology Reviews Common Genetic Conditions of Ischemic Stroke to Keep in Mind
Current Molecular Medicine